Loading
Life sciences · Journal article
Chemistryselect · October 28, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
ABSTRACT Photothermal therapy (PTT) has emerged as a promising cancer treatment strategy. Under the irradiation of an external light source, photothermal materials absorb light energy and convert it into local thermal energy, thereby ablating tumors. The performance of PTT can be further enhanced by constructing photothermal composite materials. Compared with traditional cancer treatment methods such as chemotherapy and radiotherapy, PTT has the advantages of minimally invasiveness, high targeting specificity, and low systemic toxicity. Meanwhile, precisely integrating PTT with multiple cancer treatment methods such as chemotherapy, radiotherapy, and immunotherapy on a nanoscale platform can overcome the limitations of single therapies and enhance the overall therapeutic effect. In light of the current research status in the field of cancer therapy, this review systematically summarizes the latest research achievements and progress of various photothermal nanomaterials in PTT, including inorganic nanomaterials (such as noble metal nanomaterials, transition metal sulfide/oxide nanomaterials, carbon‐based nanomaterials, and so forth) and organic nanomaterials (such as polymer‐based nanomaterials and small molecule‐based nanomaterials). Finally, the clinical prospects and remaining challenges of PTAs are critically outlined.